NEW YORK (GenomeWeb News) — Millipore yesterday said third-quarter revenues increased 38 percent as R&D spending rose 31 percent and profits slid 35 percent.

 

Total receipts for the three months ended Sept. 30 increased to $330.1 million from $239.6 million year over year. Compared with the third quarter of 2005, sales in the company’s Bioprocess segment was up 34 percent to $195 million, while its Bioscience segment gained 44 percent with sales of $135 million.